Eliminating “Zombie” Cells To Beat Cancer
Research led by Dr. Manuel Serrano at IRB Barcelona has unveiled how senescent cancer cells, post-chemotherapy, employ the PD-L2 protein to evade immune detection and foster a suppressive environment, hindering lymphocyte function. Deactivating PD-L2 in these cells allows the immune system to efficiently eliminate them, enhancing the effectiveness of chemotherapy. This finding, demonstrated in cell and animal models of various cancers, suggests the potential of PD-L2 inhibitors in improving cancer treatments. Credit:…